Skip to main content

DAPT Considerations in High Bleeding Risk Patients

Enter your credentials to view the webinar recording. If you previously accessed this program, please log-in using your email address.

How are you currently managing your complex high bleeding risk (HBR) patients on dual antiplatelet therapy (DAPT)?

This 60-minute webinar presented by Dr. Price and Dr. Latib will:

  • Review PCI cases in HBR patients
  • Define HBR patients and trials
  • Discuss stent properties that are critical for healing
  • Review Onyx ONE Global Study and Onyx ONE Clear Study results
  • Assess methods to individualize DAPT in HBR patients
  • Answer your questions throughout the discussion
Watch the Recording Now
What is your profession?

Log In

If you are already registered, look up the email address you used to register to log in below.


  • Dr. Matthew Price
    Interventional Cardiologist
    Scripps Memorial Hospital
    La Jolla, California
  • Dr. Azeem Latib
    Section Head of Interventional Cardiology & Medical Director of Structural Heart Interventions at Montefiore Health Center
    New York, New York